Rybelsus 7mg(semaglutide)Tablet

How it Works

Rybelsus, with the active ingredient semaglutide, belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists. It is used in the treatment of type 2 diabetes mellitus to improve glycemic control. Semaglutide works by mimicking the action of endogenous GLP-1, a hormone released by the intestine in response to food intake. By binding to and activating GLP-1 receptors in pancreatic beta cells, semaglutide stimulates insulin secretion in a glucose-dependent manner. It also suppresses glucagon secretion, slows gastric emptying, and promotes satiety, which collectively contribute to lower blood sugar levels.

Side Effects

• Nausea
• Diarrhea
• Abdominal pain
• Decreased appetite
• Indigestion
• Vomiting
• Headache
• Dizziness
• Fatigue
• Hypoglycemia (low blood sugar)
• Upper respiratory tract infection
• Back pain
• Constipation

Indications

• Rybelsus 7mg Tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Contraindications

• Hypersensitivity to semaglutide or any of its excipients
• Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
• Patients with severe gastrointestinal disease
• History of pancreatitis
• Patients with gastroparesis
• Patients with severe renal impairment (eGFR less than 30 mL/min/1.73 m²)

Price Comparison in Different Countries

Country	Price (USD)	Website
United States	$400 per month	GoodRx
Canada	$350 per month	PharmacyChecker
United Kingdom	?300 per month	NHS
Australia	AUD 500 per month	PBS
Germany	?350 per month	Aponeo

Top 5 Global Brands

1. Rybelsus (Novo Nordisk)
2. Trulicity (Eli Lilly)
3. Victoza (Novo Nordisk)
4. Byetta (AstraZeneca)
5. Ozempic (Novo Nordisk)